Targeting the residual progression of chronic kidney disease with type-2 diabetes beyond the renoprotective effects of a metformin-ramipril-empagliflozin combination
Online Katalog der Universitätsbibliothek der LMU München (1/1)
Ablegen in:
Targeting the residual progression of chronic kidney disease with type-2 diabetes beyond the renoprotective effects of a metformin-ramipril-empagliflozin combination
Targeting the residual progression of chronic kidney disease with type-2 diabetes beyond the renoprotective effects of a metformin-ramipril-empagliflozin combination